ArticleHealth affairs (Project Hope)2017
Hepatitis C Testing Increased Among Baby Boomers Following The 2012 Change To CDC Testing Recommendations.
Article in Health affairs (Project Hope), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed.
- Hepatitis C Screening: A Health Technology Assessment.Ontario health technology assessment series · 2026Article
- Testing trends and co-testing patterns for HIV, hepatitis C and sexually transmitted infections (STIs) in Emergency departments.Preventive medicine reports · 2024Article
- Bridging Hepatitis C Care Gaps: A Modeling Approach for Achieving the WHO's Targets in Ontario, Canada.Viruses · 2024Article
- Article
- A province-by-province cost-effectiveness analysis and budget impact analysis of one-time birth cohort screening of hepatitis C virus (HCV) infection in Canada.Scientific reports · 2023Article
- Hepatitis C Virus Screening among Baby Boomers: The Positive Benefits of Health Education and Outreach during the COVID-19 Pandemic.Healthcare (Basel, Switzerland) · 2023Article
- Medicaid Hepatitis C Virus Treatment Policies: Impact on Testing and Treatment in the Commercially Insured.American journal of preventive medicine · 2022Article
- The Hepatitis C Care Cascade During the Direct-Acting Antiviral Era in a United States Commercially Insured Population.Open forum infectious diseases · 2022Article
- Semi-automated Clinical Content Curation of COVID-19 Chatbot Remote Patient Monitoring Solution.AMIA ... Annual Symposium proceedings. AMIA Symposium · 2022Article
- Cascade of Hepatitis C Virus Care Among Patients With Substance Use Disorders.American journal of preventive medicine · 2021Article
- Linkage to specialty care in the hepatitis C care cascade.Journal of investigative medicine : the official publication of the American Federation for Clinical Research · 2021Article
- Hepatitis C Management at Federally Qualified Health Centers during the Opioid Epidemic: A Cost-Effectiveness Study.The American journal of medicine · 2020Article
- Time for a New Approach to Guidance for Human Immunodeficiency Virus and Hepatitis C Virus Testing Among Persons Who Inject Drugs.The Journal of infectious diseases · 2020Article
- Screening for Hepatitis C Virus: How Universal Is Universal?Clinical therapeutics · 2020Review
- The Cost of Hepatitis C Testing Strategies in Primary Care Patients with Abnormal Transaminases.Journal of general internal medicine · 2020Article
- Differential Impact of Age Among Liver Transplant Candidates With and Without Hepatocellular Carcinoma.Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society · 2020Article
- The Association of Abnormal Liver Tests with Hepatitis C Testing in Primary Care.The American journal of medicine · 2020Article
- Addressing Hepatitis C in the American Incarcerated Population: Strategies for Nationwide Elimination.Current HIV/AIDS reports · 2020Review
- Contact tracing for hepatitis C: The case for novel screening strategies as we strive for viral elimination.The International journal on drug policy · 2019Article
- Late diagnosis of hepatitis C virus infection, 2014-2016: continuing missed intervention opportunities.The American journal of managed care · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
In 2012 the Centers for Disease Control and Prevention recommended routine testing for hepatitis C for people born in the period 1945-65. Until now, the recommendation's impact on hepatitis C screening rates in the United States has not been fully understood. We used an interrupted time series with comparison group design to analyze hepatitis C screening rates in the period 2010-14 among 2.8 million commercially insured adults in the MarketScan database. Hepatitis C screening rates increased yearly between 2010 and 2014, from 1.65 to 2.59 per 100 person-years. A 49 percent increase in screening rates among people born during 1945-65 followed the release of the recommendation, but no such increase was observed among adults born after 1965. The effect among the target population was sustained, and by twenty-four months after the recommendation's release, screening rates had increased 106 percent. We conclude that the hepatitis C testing policy change resulted in significantly increased testing among the target population and may have decreased the magnitude of the hepatitis C epidemic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.